StageZero to Issue Q1 2022 Financial Results and Hold Conference Call on Tuesday May 17
TORONTO, ON / ACCESSWIRE / May 13, 2022 / StageZero Life Sciences ("StageZero" or the "Company") (TSX:SZLS) today announced that...
TORONTO, ON / ACCESSWIRE / May 13, 2022 / StageZero Life Sciences ("StageZero" or the "Company") (TSX:SZLS) today announced that...
WYOMISSING, Pa., May 13, 2022 (GLOBE NEWSWIRE) -- TRIOSE Inc., the leading provider of intelligent healthcare supply chain solutions, is...
Phase 3 study of LB1148 in lead indication for postoperative return of bowel function on track to commence Q2 2022...
PGX Technology continues to demonstrate ability to generate novel bioactive delivery systems for nutraceuticals, drug delivery and wound healingEDMONTON, Alberta,...
MARKHAM, Ontario, May 13, 2022 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“Sienna” or the “Company”) (TSX: SIA) today announced...
FREMONT, CA, May 13, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical...
Ozop Plus is Reinsurance Symposium Premier Sponsor Florida, NY, May 13, 2022 (GLOBE NEWSWIRE) -- Ozop Energy Solutions. Inc. (OZSC),...
Waivers remove requirement to conduct pediatric clinical studies to support cosibelimab marketing authorization applications in EuropeWALTHAM, Mass., May 13, 2022...
POINT's manufacturing facility initiated supply for the Phase 3 SPLASH trial. Randomization of patients for the SPLASH trial expanded to...
PHILADELPHIA, PA, May 13, 2022 (GLOBE NEWSWIRE) -- Vallon Pharmaceuticals, Inc. (NASDAQ: VLON), (“Vallon” or the “Company”), a clinical-stage biopharmaceutical...
Company looks to improve capital structure and create long-term value for all security holdersTORONTO, May 13, 2022 (GLOBE NEWSWIRE) --...
GLENDALE, Calif., May 13, 2022 (GLOBE NEWSWIRE) -- The hemp products filled with different cannabinoids have become very popular as...
ONS-5010 / LYTENAVA™ (bevacizumab-vikg) Biologics License Application (BLA) submitted to U.S. Food and Drug Administration (FDA); PDUFA date expected to...
CAMBRIDGE, Mass., May 13, 2022 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a multi-asset multi-modality company focused on developing...
VANCOUVER, Washington, May 13, 2022 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing...
MOUNTAIN VIEW, Calif., May 13, 2022 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on...
SEATTLE and VANCOUVER, British Columbia, May 13, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical...
Conference call scheduled for 8:30 a.m. ET todayMIAMI, May 13, 2022 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or...
AcQBlate FORCE System A complete ablation system which includes the smallest footprint of any RF Generator and is comprised of...
Progressive Care Inc. Has Scheduled an Investor Conference Call for 4:30 PM ET on Tuesday, May 17, 2022 MIAMI, FL,...